140 related articles for article (PubMed ID: 22160906)
1. Expression of multisubunit proteins in Leishmania tarentolae.
Sugino M; Niimi T
Methods Mol Biol; 2012; 824():317-25. PubMed ID: 22160906
[TBL] [Abstract][Full Text] [Related]
2. The production of recombinant human laminin-332 in a Leishmania tarentolae expression system.
Phan HP; Sugino M; Niimi T
Protein Expr Purif; 2009 Nov; 68(1):79-84. PubMed ID: 19607924
[TBL] [Abstract][Full Text] [Related]
3. Recombinant protein production in the eukaryotic protozoan parasite Leishmania tarentolae: a review.
Niimi T
Methods Mol Biol; 2012; 824():307-15. PubMed ID: 22160905
[TBL] [Abstract][Full Text] [Related]
4. Leishmania tarentolae for the Production of Multi-subunit Complexes.
Niimi T
Adv Exp Med Biol; 2016; 896():155-65. PubMed ID: 27165324
[TBL] [Abstract][Full Text] [Related]
5. Artificial linear episome-based protein expression system for protozoon Leishmania tarentolae.
Kushnir S; Cirstea IC; Basiliya L; Lupilova N; Breitling R; Alexandrov K
Mol Biochem Parasitol; 2011 Apr; 176(2):69-79. PubMed ID: 21167214
[TBL] [Abstract][Full Text] [Related]
6. Isotopic labeling of recombinant proteins expressed in the protozoan host Leishmania tarentolae.
Niculae A; Bayer P; Cirstea I; Bergbrede T; Pietrucha R; Gruen M; Breitling R; Alexandrov K
Protein Expr Purif; 2006 Aug; 48(2):167-72. PubMed ID: 16740394
[TBL] [Abstract][Full Text] [Related]
7. Development of an inducible protein expression system based on the protozoan host Leishmania tarentolae.
Kushnir S; Gase K; Breitling R; Alexandrov K
Protein Expr Purif; 2005 Jul; 42(1):37-46. PubMed ID: 15939291
[TBL] [Abstract][Full Text] [Related]
8. Expression of human tissue plasminogen activator in the trypanosomatid protozoan Leishmania tarentolae.
Soleimani M; Mahboudi F; Davoudi N; Amanzadeh A; Azizi M; Adeli A; Rastegar H; Barkhordari F; Mohajer-Maghari B
Biotechnol Appl Biochem; 2007 Sep; 48(Pt 1):55-61. PubMed ID: 17371294
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of recombinant human tissue plasminogen activator in Leishmania tarentolae.
Hemayatkar M; Mahboudi F; Majidzadeh-A K; Davami F; Vaziri B; Barkhordari F; Adeli A; Mahdian R; Davoudi N
Biotechnol J; 2010 Nov; 5(11):1198-206. PubMed ID: 21058320
[TBL] [Abstract][Full Text] [Related]
10. Comparative expression of wild-type and highly soluble mutant His103Leu of hydroxynitrile lyase from Manihot esculenta in prokaryotic and eukaryotic expression systems.
Dadashipour M; Fukuta Y; Asano Y
Protein Expr Purif; 2011 May; 77(1):92-7. PubMed ID: 21185385
[TBL] [Abstract][Full Text] [Related]
11. Exploiting Leishmania tarentolae cell-free extracts for the synthesis of human solute carriers.
Ruehrer S; Michel H
Mol Membr Biol; 2013 Jul; 30(4):288-302. PubMed ID: 23802133
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the growth behavior of Leishmania tarentolae: a new expression system for recombinant proteins.
Fritsche C; Sitz M; Weiland N; Breitling R; Pohl HD
J Basic Microbiol; 2007 Oct; 47(5):384-93. PubMed ID: 17910102
[TBL] [Abstract][Full Text] [Related]
13. Recombinant protein expression in Leishmania tarentolae.
Basile G; Peticca M
Mol Biotechnol; 2009 Nov; 43(3):273-8. PubMed ID: 19779853
[TBL] [Abstract][Full Text] [Related]
14. Expression of human c-reactive protein in different systems and its purification from Leishmania tarentolae.
Dortay H; Schmöckel SM; Fettke J; Mueller-Roeber B
Protein Expr Purif; 2011 Jul; 78(1):55-60. PubMed ID: 21440634
[TBL] [Abstract][Full Text] [Related]
15. A system for concomitant overexpression of four periplasmic folding catalysts to improve secretory protein production in Escherichia coli.
Schlapschy M; Grimm S; Skerra A
Protein Eng Des Sel; 2006 Aug; 19(8):385-90. PubMed ID: 16720693
[TBL] [Abstract][Full Text] [Related]
16. Expression of heterologous proteins in Pichia pastoris: a useful experimental tool in protein engineering and production.
Daly R; Hearn MT
J Mol Recognit; 2005; 18(2):119-38. PubMed ID: 15565717
[TBL] [Abstract][Full Text] [Related]
17. Development of a defined medium for heterologous expression in Leishmania tarentolae.
Fritsche C; Sitz M; Wolf M; Pohl HD
J Basic Microbiol; 2008 Dec; 48(6):488-95. PubMed ID: 18759244
[TBL] [Abstract][Full Text] [Related]
18. Leishmania tarentolae: utility as an in vitro model for screening of antileishmanial agents.
Taylor VM; Muñoz DL; Cedeño DL; Vélez ID; Jones MA; Robledo SM
Exp Parasitol; 2010 Dec; 126(4):471-5. PubMed ID: 20685203
[TBL] [Abstract][Full Text] [Related]
19. Cloning and expression of truncated form of tissue plasminogen activator in Leishmania tarentolae.
Nazari R; Davoudi N
Biotechnol Lett; 2011 Mar; 33(3):503-8. PubMed ID: 21120587
[TBL] [Abstract][Full Text] [Related]
20. Towards the construction of expressed proteomes using a Leishmania tarentolae based cell-free expression system.
Kovtun O; Mureev S; Johnston W; Alexandrov K
PLoS One; 2010 Dec; 5(12):e14388. PubMed ID: 21203562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
